Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

AbbVie to buy Pharmacyclics for $21 billion

Country: United States

AbbVie Inc has raised the bar for oncology acquisitions with an agreement to buy Pharmacyclics Inc and its recently approved drug Imbruvica (ibrutinib) for blood cancers for a cash and share offer totaling $21 billion. The deal has been approved by the boards of both companies.

Read more

Newron readies first product for market

Country: Italy

Newron Pharmaceuticals S.p.A reported a fall in revenue and a widening of its annual operating loss in 2014 as it prepared to bring its first product to market – an add-on treatment for mid-to-late stage Parkinson’s disease.

Read more

Nikon moves into healthcare

Country: Japan

Read more

Orphan drug gets EMA nod

Country: United Kingdom

Read more

Positive opinion for Zykadia

Country: United Kingdom

Read more

New indication recommended for Avastin

Country: United Kingdom

Read more

Analysis: Circassia on track

Country: United Kingdom

Read more

Cardio3 completes private placement

Country: Belgium

Read more

Re-setting the compass at UCB

Country: Belgium

Read more

MorphoSys highlights pipeline

Country: Germany

Read more

Ablynx reports 37% revenue gain

Country: Belgium

Read more

FDA approves Toujeo for diabetes

Country: France

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Ebola epidemic moves fast but response is gaining

EbolaFeb2015.pdf

Highlights of the February 2015 MedNous issue

The February 2015 MedNous features:

Latest Mednous cover
  • Public Health
    Getting Ebola under control
  • Research Strategy
    What does the brain hear?
    Interview with Autifony
  • Business Strategy
    A turning point for biopharma?
    By Jean-Claude Muller
  • Commentary
    Tackling infections associated with cystic fibrosis
    by Deborah O’Neil
  • Commentary
    Innovation points to a bright future
    by Mick Cooper
  • Big Pharma Review
    Deriving value from asset swaps
    By Martin Gouldstone

The latest MedNous journal. Subscribe to download.

Recent Appointments